164 related articles for article (PubMed ID: 8624152)
1. A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma.
Dummer R; Potoczna N; Häffner AC; Zimmermann DR; Gilardi S; Burg G
Arch Dermatol; 1996 May; 132(5):550-3. PubMed ID: 8624152
[TBL] [Abstract][Full Text] [Related]
2. CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.
Kato N; Yasukawa K; Kimura K; Sugawara H; Aoyagi S; Mishina T; Nakata T
J Am Acad Dermatol; 2001 Feb; 44(2):231-8. PubMed ID: 11174380
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
4. CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.
Savoia P; Fierro MT; Novelli M; Quaglino P; Verrone A; Geuna M; Bernengo MG
Br J Dermatol; 1997 Dec; 137(6):966-71. PubMed ID: 9470917
[TBL] [Abstract][Full Text] [Related]
5. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
6. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
7. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
[TBL] [Abstract][Full Text] [Related]
10. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
11. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
13. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
14. Do primary cutaneous non-T non-B CD4+CD56+ lymphomas belong to the myelo-monocytic lineage?
Bagot M; Bouloc A; Charue D; Wechsler J; Bensussan A; Boumsell L
J Invest Dermatol; 1998 Dec; 111(6):1242-4. PubMed ID: 9856854
[No Abstract] [Full Text] [Related]
15. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases.
Beltraminelli H; Leinweber B; Kerl H; Cerroni L
Am J Dermatopathol; 2009 Jun; 31(4):317-22. PubMed ID: 19461234
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?
Dummer R; Cozzio A; Urosevic M
Exp Dermatol; 2006 May; 15(5):392-400. PubMed ID: 16630081
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
18. MY7 monoclonal antibody for diagnosis of cutaneous T-cell lymphoma.
Dreno B; Bureau B; Stalder JF; Litoux P
Arch Dermatol; 1990 Nov; 126(11):1454-6. PubMed ID: 2146925
[TBL] [Abstract][Full Text] [Related]
19. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
[TBL] [Abstract][Full Text] [Related]
20. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement.
Ritter JH; Wick MR; Adesokan PN; Fitzgibbon JF; Zhu X; Humphrey PA
Am J Clin Pathol; 1997 Jul; 108(1):60-8. PubMed ID: 9208979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
